Rallybio (RLYB) Trade Update – Monday, 26 November 2026
- Closing Price – Rallybio shares closed 1.46 % higher at USD 16.64 during the 24‑hour period ending at 11:57 AM Central Europe time.
- Volume – Approximately USD 103,200 worth of shares were traded in the last 24 hours.
- Market Capitalisation – The company currently has a market cap of USD 88.4 million.
- Outstanding Shares – The outstanding share count is 5.3 million.
Technical Indicators
- Simple Moving Average (200‑day) – The 200‑day SMA is USD 12.68.
- 52‑Week High / Low – The highest price in the past 52 weeks was USD 17.57 on 1 June 2026; the lowest price was USD 3.67 on 17 February 2026.
Recent Performance
- Since the end of the previous month, Rallybio shares have increased by 0.18 %.
Comparison with Peer Companies (24‑Hour Performance)
| Company | Ticker | 24‑Hour Change | Current Price | Market Capitalisation |
|---|---|---|---|---|
| East West Ave Acquisition | EWAVU | Down 0.1 % | USD 10.03 | USD 103.5 million |
| Championsgate Acquisition | CHPG | Up 0.19 % | USD 10.52 | USD 104.9 million |
| Anixa Biosciences | ANIX | Up 7.55 % | USD 2.99 | USD 103.9 million |
| Melar Acquisition I | MACI | Down 3.21 % | USD 11.00 | USD 105 million |
| Surf Air Mobility | SRFM | Down 3.12 % | USD 0.78 | USD 103 million |
Company Overview – Rallybio Corporation
Rallybio Corporation is a clinical‑stage biotechnology firm that focuses on the discovery, development, manufacturing, and supply of therapies designed to improve the lives of patients in the United States who suffer from severe and rare diseases. The company’s pipeline and development programs are oriented toward addressing unmet medical needs in this patient population.
